- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03230981
Age-dependency of Cornea Biomechanics Using OCT Vibrography
Age-dependency of Cornea Biomechanics Measured by OCT Vibrography: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The cornea, the clear front window of the eye, consists of finely intertwined collagen fibers, which give the cornea a microstructure that provides mechanical integrity necessary to maintain its typical dome-shape against the intraocular pressure (IOP). Changes in the biomechanical properties can lead to an abnormal corneal shape and refractive errors. As a result, light is not perfectly focused onto the retina and the vision is affected. A typical example of alterations in the cornea's biomechanical properties is found in patients with an eye disorder called Keratoconus, which leads to progressive thinning of the cornea. Numerous studies have shown that promising interventions like collagen crosslinking (CXL) can slow down an arrest progression of ectatic eye diseases. Keratoconus, as a typical example, although it cannot be cured, could be at least halted by CXL. Therefore, early diagnosis of ectasia is crucial for the patient. Current diagnostic methods of ectasia are based on morphological rather than biomechanical analysis. The irregular patterns of the cornea can be detected by pachymetry and topography before clinical signs occur, but these tests cannot reliably differentiate truly weak or keratoconic corneas from atypical normal ones.
These are compelling needs for improved diagnostic methods. More recently, and triggered by those unmet needs, an interest in the mechanical properties of the cornea has emerged. Typical examples of mechanical properties are elastic modulus and corneal stiffness.
In this pilot study the investigators will test the ability of a new OCT Vibrography system to determine cornea material parameters. More precisely, the investigators will study the oscillation response in human corneas in-vivo using a stimulus mechanism used to induce vibrations by touching the surface of the cornea. A localized vibration source paired together with phase-sensitive OCT to measure the frequency response function of the human cornea and to analyze the dependency of the frequency response function on age. Additionally the investigators will use Brillouin Microscopy data for computer simulations to validate OCT Vibrography results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female subjects between the ages of 18 to 79 years
- Healthy normal subjects with no significant eye disease and no significant refractive errors
Exclusion Criteria:
- Volunteers with implanted intraocular lenses
- Volunteers with LASIK or any other eye surgery, and monocular volunteers
- Volunteers with restricted mobility, who cannot stand up, walk or sit still on a chair without a back
- Subjects who do not or cannot understand the instructions for imaging
- Subjects with diabetes, glaucoma family history
- Subjects who are pregnant and/or breastfeeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy subjects
Optical imaging of the cornea in healthy subjects
|
OCT vibrography and Brillouin microscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.
Time Frame: 1 year
|
Frequency and severity of all treatment-related adverse events
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validation of OCT Vibrography data by means of Brillouin microscopy measurements of the in-vivo cornea
Time Frame: 1 year
|
Use of Brillouin microscopy in-vivo data for computer simulations to validate OCT Vibrography results.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Seok-Hyun Yun, PhD, Massachusetts General Hospital
Publications and helpful links
General Publications
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003 May;135(5):620-7. doi: 10.1016/s0002-9394(02)02220-1.
- de Sanctis U, Loiacono C, Richiardi L, Turco D, Mutani B, Grignolo FM. Sensitivity and specificity of posterior corneal elevation measured by Pentacam in discriminating keratoconus/subclinical keratoconus. Ophthalmology. 2008 Sep;115(9):1534-9. doi: 10.1016/j.ophtha.2008.02.020. Epub 2008 Apr 11.
- Li X, Rabinowitz YS, Rasheed K, Yang H. Longitudinal study of the normal eyes in unilateral keratoconus patients. Ophthalmology. 2004 Mar;111(3):440-6. doi: 10.1016/j.ophtha.2003.06.020.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017P000867
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cornea
-
OptovueCompletedCataract Surgery | Normal Cornea | Post Laser Refractive Surgery | Cornea PathologyUnited States
-
Daniela NoschCompleted
-
University of Missouri-ColumbiaUniversity of South FloridaTerminatedKeratoconus | Cornea EctasiaUnited States
-
Augenarztpraxis BreisachUnknown
-
National Taiwan University HospitalUnknown
-
Carl Zeiss Meditec, Inc.ClinReg Consulting Services, Inc.; Sierra Clinical Services, LLCCompleted
-
Fayoum UniversityNot yet recruiting
-
AcuFocus, Inc.CompletedCataract | Presbyopia | Irregular; Contour of CorneaSingapore
-
Occyo GmbHUniversity Clinic for Ophthalmology and Optometry- SalzburgCompletedLimbal Stem-cell Deficiency | Cornea Disease | Eyes Dry Chronic | Chronic Conjunctivitis of Both Eyes | Eye Lesion | Eye Disease; Cataract | Eyes Dry Feeling of | Cornea Inflamed | Cornea; Injury, Abrasion | Cornea InfectionAustria
-
Case Western Reserve UniversityNational Eye Institute (NEI); Jaeb Center for Health ResearchCompletedCornea Preservation Time | Endothelial Keratoplasty | Transplant Success | Endothelial Cell DensityUnited States
Clinical Trials on Optical imaging of the cornea in healthy subjects
-
International Agency for Research on CancerFederico II University; Imperial College London; Fondazione IRCCS Istituto Nazionale... and other collaboratorsCompleted
-
Massachusetts General HospitalMassachusetts Eye and Ear InfirmaryRecruitingSkin Diseases | Gingival Diseases | CorneaUnited States
-
Institut Claudius RegaudUnknownHereditary Breast and Ovarian Cancer | Hereditary Cancer Syndrome | Hereditary Colorectal Endometrial Cancer SyndromeFrance
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Jiangsu Taizhou People's HospitalCompletedHealthy ParticipantsChina
-
University of FloridaCompletedCongenital Cardiovascular MalformationUnited States
-
Danone Global Research & Innovation CenterCompletedA03 - Digestive System | B03 - BacteriaFrance
-
ThromboGenicsBioInvent International ABCompleted
-
YMD Eye and FaceCompletedFacial WrinklesUnited States
-
Université Catholique de LouvainNot yet recruitingHealthy | Young Healthy Adults